Jane Huang - May 28, 2021 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
May 28, 2021
Transactions value $
-$686,046
Form type
4
Date filed
6/2/2021, 04:40 PM
Next filing
Jun 9, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE Ordinary Shares Award $0 +7.19K +2.52% $0.00 293K May 31, 2021 Direct F1
transaction BGNE American Depositary Shares Award $0 +540 $0.00 540 May 31, 2021 Direct F1, F2
transaction BGNE American Depositary Shares Options Exercise $44.2K +1.5K $29.49* 1.5K May 28, 2021 Direct F2
transaction BGNE American Depositary Shares Sale -$35.3K -100 -6.67% $352.85 1.4K May 28, 2021 Direct F2, F3
transaction BGNE American Depositary Shares Sale -$177K -500 -35.71% $354.97 900 May 28, 2021 Direct F2, F3, F4
transaction BGNE American Depositary Shares Sale -$107K -300 -33.33% $356.21 600 May 28, 2021 Direct F2, F3, F5
transaction BGNE American Depositary Shares Sale -$126K -353 -58.83% $357.50 247 May 28, 2021 Direct F2, F3, F6
transaction BGNE American Depositary Shares Sale -$52.7K -147 -59.51% $358.36 100 May 28, 2021 Direct F2, F3, F7
transaction BGNE American Depositary Shares Sale -$35.9K -100 -100% $359.42 0 May 28, 2021 Direct F2, F3
transaction BGNE American Depositary Shares Sale -$196K -540 -100% $362.64 0 Jun 1, 2021 Direct F2, F8, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BGNE Share Option (Right to Buy) Options Exercise $0 -19.5K -7.91% $0.00 227K May 28, 2021 Ordinary Shares 19.5K $2.27 Direct F10, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions.
F2 Each American Depositary Share represents 13 Ordinary Shares.
F3 The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2019.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $354.73 to $355.22, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.85 to $356.41, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.93 to $357.81, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.01 to $358.53, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F8 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a performance-based restricted share unit award previously granted to the Reporting Person.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.57 to $362.72, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F10 The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
F11 These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events.